Experts Urge Review of Tobacco Inter-generational Endgame Law in Malaysia

Aug.17.2022
Experts Urge Review of Tobacco Inter-generational Endgame Law in Malaysia
A Malaysian think tank urges parliament to review the proposed tobacco law to remove criminalizing smoking for those born after 2007.

A Malaysian think tank has urged the Parliamentary Select Committee (PSSC) to review the Tobacco Control and Smoking (GEG) Bill to remove Section 17, which criminalizes the use of tobacco products and smoking devices for those born in or after 2007. The provision also extends to electronic cigarettes.


Source: Butenkow


Azrul Mohd Khalib, the CEO of the Galen Health and Social Policy Center, has stated that the law should place pressure on retailers and companies to bear the responsibility of not selling or supplying tobacco and e-cigarette products to the Generation E Generation (GEG).


In a statement, Azrul expressed concerns that Article 17 of the proposed legislation could lead to selective prosecution and stigmatization of certain groups in need of support. He also acknowledged that despite efforts to enforce the rules, people within the GEG community may still smoke or become addicted to nicotine through e-cigarettes. The statement raises the question of whether or not punitive measures should be taken against such individuals.


Legislation should ensure that it is a crime to sell or supply tobacco or e-cigarette products to anyone born after January 1, 2007. Azrul emphasized that anyone addicted to nicotine has the right to equal treatment under the law, with compassion and dignity. He said the proposed GEG bill should not disproportionately affect young people, low-income groups, and vulnerable populations.


Statement


This article has been compiled based on third-party information and is intended for industry exchange and learning purposes.


This article does not reflect the views of 2FIRSTS and the company cannot confirm the authenticity or accuracy of its content. The translation of this article is solely intended for industry communication and research.


Due to limitations in translation ability, the translated article may not fully convey the same meaning as the original text. Therefore, the original text should be considered the authoritative version.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


All compiled information is owned by the original media and authors. If there is any infringement, please contact us to have it removed.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
The U.S. FDA has launched a pilot program for PMTA review of nicotine pouches to expedite the approval process and enhance regulatory efficiency
In Sept 2025, the US FDA launched a nicotine pouch PMTA pilot to boost review efficiency, streamline processes and uphold strict scientific standards. Based on the "tobacco product health risk continuum" concept, it shortens cycles by focusing on key product factors and enhancing real-time communication with applicants. The FDA also urges child-resistant packaging to tackle kids’ accidental exposure, emphasizes scientific review for new tobacco products, and has approved 20 nicotine pouches so f
Sep.19 by 2FIRSTS.ai
The Pinnacle of Craftsmanship: Great Wall Cigars' Exclusive 2025 Releases
The Pinnacle of Craftsmanship: Great Wall Cigars' Exclusive 2025 Releases
Great Wall Cigars presents its latest premium collection, blending Chinese heritage with global craftsmanship. From the Cameroon-tobacco GX Lion’s Glory Toro to the zodiac-themed Year of the Horse and Year of the Snake editions, each cigar embodies artistry and rarity. Alongside the refined Spectacular No.2 and No.3 Extra Finos, the lineup marks Great Wall’s rise as a symbol of Chinese cigar excellence on the world stage.
Oct.11
Jerome Abelman to Step Down as General Counsel of British American Tobacco After 23-Year Career; Paul McCrory Named as Successor
Jerome Abelman to Step Down as General Counsel of British American Tobacco After 23-Year Career; Paul McCrory Named as Successor
British American Tobacco (BAT) has announced that Legal Director and General Counsel Jerome Abelman will leave in late 2025 after 23 years. He will be succeeded in 2026 by Paul McCrory, the current Director of Corporate and Regulatory Affairs. CEO Tadeu Marroco commended Abelman’s service and stated the transition supports the group’s strategic priorities.
Sep.12 by 2FIRSTS.ai
Hartlepool Convenience Store has Alcohol License Revoked for Illegally Selling e-Cigarettes and Tobacco to Minors
Hartlepool Convenience Store has Alcohol License Revoked for Illegally Selling e-Cigarettes and Tobacco to Minors
A convenience store in Hartlepool, England, had its alcohol sales licence revoked for illegally selling e-cigarettes and tobacco to minors, and the new licence holder has taken remedial measures.
Sep.16 by 2FIRSTS.ai
Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male
Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male
Russia’s Chair of the State Duma Committee on Youth Policy warns that among 11–14-year-olds, girls now vape at higher rates than boys, a trend he calls “deeply concerning.” He says the spread of nicotine products—especially e-cigarettes—among minors poses a public health risk and warrants continued policy-level interventions.
Oct.17 by 2FIRSTS.ai